Literature DB >> 23066113

Targeting YAP acetylation in cancer.

Lan Sun, Lingli Tu, You Lu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23066113      PMCID： PMC3471730          DOI： 10.1074/jbc.L112.399592

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  5 in total

1.  Cancer stem cells: TAZ takes centre stage.

Authors:  Mhairi Skinner
Journal:  Nat Rev Cancer       Date:  2012-01-19       Impact factor: 60.716

2.  Role of YAP/TAZ in mechanotransduction.

Authors:  Sirio Dupont; Leonardo Morsut; Mariaceleste Aragona; Elena Enzo; Stefano Giulitti; Michelangelo Cordenonsi; Francesca Zanconato; Jimmy Le Digabel; Mattia Forcato; Silvio Bicciato; Nicola Elvassore; Stefano Piccolo
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

3.  Quit your YAPing: a new target for cancer therapy.

Authors:  Ben Z Stanger
Journal:  Genes Dev       Date:  2012-06-15       Impact factor: 11.361

4.  A novel acetylation cycle of transcription co-activator Yes-associated protein that is downstream of Hippo pathway is triggered in response to SN2 alkylating agents.

Authors:  Shoji Hata; Jun Hirayama; Hiroaki Kajiho; Kentaro Nakagawa; Yutaka Hata; Toshiaki Katada; Makoto Furutani-Seiki; Hiroshi Nishina
Journal:  J Biol Chem       Date:  2012-04-27       Impact factor: 5.157

Review 5.  The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway.

Authors:  Wanjin Hong; Kun-Liang Guan
Journal:  Semin Cell Dev Biol       Date:  2012-05-29       Impact factor: 7.727
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.